Trial Profile
A Phase 2 Study Of The Efficacy And Safety Of SU011248 In Patients With Metastatic Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2009
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 17 Sep 2005 New trial record.